STOCK TITAN

Art’s Way director granted 1,000 stock shares

A non-cash director compensation grant increased Thomas E. Buffamante’s directly held ARTW shares to 65,000.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ARTS WAY MANUFACTURING CO INC (symbol: ARTW) is the issuer of record for a Form 4 filing submitted to the SEC. Buffamante Thomas E reported acquisition or exercise transactions in this Form 4 filing.

ARTS WAY MANUFACTURING CO INC (ARTW) reported that director Thomas E. Buffamante received an award of 1,000 shares of Common Stock on August 31, 2026. The shares are fully-vested restricted stock granted under a director compensation plan, and his directly held stake increased to 65,000 shares. No Rule 10b5-1 trading plan is reported for this award.

Positive

  • None.

Negative

  • None.
Insider Buffamante Thomas E
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 1,000 $0.00 $0.00
Holdings After Transaction: Common Stock — 65,000 shares (Direct)
Footnotes (1)
  1. F1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.
Shares granted 1,000 shares of Common Stock Fully-vested restricted stock award on August 31, 2026
Price per share for grant $0.00 per share Reported value for the 1,000-share compensation grant
Shares owned after transaction 65,000 shares Director’s directly held Common Stock following the August 31, 2026 award
restricted stock financial
"Represents fully-vested restricted stock granted pursuant to the director compensation plan"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
fully-vested financial
"Represents fully-vested restricted stock granted pursuant to the director compensation plan"
director compensation plan financial
"restricted stock granted pursuant to the director compensation plan"

FAQ

What did ARTW director Thomas E. Buffamante report on this Form 4 for ARTS WAY MANUFACTURING CO INC (ARTW)?

He reported an award of 1,000 shares of Common Stock on August 31, 2026. The filing describes this as fully-vested restricted stock granted under a director compensation plan, increasing his directly held ownership to 65,000 shares.

Was the ARTW Form 4 transaction a market purchase or sale?

The Form 4 reports a grant or award acquisition of 1,000 shares of Common Stock, not a market purchase or sale. The shares were granted as fully-vested restricted stock under a director compensation plan.

How many ARTW shares does Thomas E. Buffamante hold after this reported grant?

After the reported grant, Thomas E. Buffamante directly holds 65,000 shares of ARTS WAY MANUFACTURING CO INC Common Stock. This total includes the 1,000 fully-vested restricted shares granted on August 31, 2026.

What was the reported price per share for the ARTW stock grant on this Form 4?

The Form 4 reports a price per share of $0.00 for the 1,000-share award. This reflects that the shares were granted as compensation, described as fully-vested restricted stock under a director compensation plan, rather than purchased in the market.

Was the ARTW Form 4 transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not marked as affirmative, so no Rule 10b5-1 trading plan is reported in connection with this award of 1,000 fully-vested restricted shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Buffamante Thomas E

(Last)(First)(Middle)
5556 HIGHWAY 9

(Street)
ARMSTRONG IOWA 50514

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ARTS WAY MANUFACTURING CO INC [ ARTW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/31/2026A1,000(1)A$065,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.
/s/ Michael W. Woods as Attorney-in-Fact for Thomas E. Buffamante09/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)